Vivos Therapeutics Inc.

NASDAQ: VVOS · Real-Time Price · USD
4.61
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
4.33
-6.07%
After-hours: Aug 14, 2025, 07:59 PM EDT

Vivos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
15.03M 13.8M 16.02M 16.89M
Cost of Revenue
6.01M 5.53M 6M 4.28M
Gross Profit
9.02M 8.27M 10.02M 12.6M
Operating Income
-11.17M -17.3M -25.03M -19.47M
Interest Income
n/a n/a 89K 117K
Pretax Income
-11.14M -13.58M -23.84M -20.29M
Net Income
-11.14M -13.58M -22.66M -20.29M
Selling & General & Admin
19.61M 24.85M 34.38M 31.34M
Research & Development
n/a 100K 200K n/a
Other Expenses
581K 621K 669K 733K
Operating Expenses
20.19M 25.57M 35.05M 32.08M
Interest Expense
n/a n/a n/a 14K
Selling & Marketing Expenses
1.73M 2.47M 5.34M 5.55M
Cost & Expenses
25.62M 31.1M 41.05M 36.36M
Income Tax Expense
n/a n/a -1.19M 5K
Shares Outstanding (Basic)
5.02M 1.22M 920.48K 849.32K
Shares Outstanding (Diluted)
5.02M 1.22M 920.48K 849.32K
EPS (Basic)
-1.68 -11.14 -24.62 -23.89
EPS (Diluted)
-1.68 -11.14 -24.62 -23.89
EBITDA
-10.55M -16.68M -24.36M -19.54M
EBIT
-11.17M -17.3M -25.03M -20.27M
Depreciation & Amortization
581K 621K 669K 733K